Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study
BackgroundIn psoriatic arthritis (PsA), the primary goal of treatment is clinical remission. This study aimed to characterize the molecular profile underlying the induced clinical remission in patients with PsA, comparing the remission state and the healthy condition.MethodsWhole blood transcriptomi...
Main Authors: | Maria Maddalena Angioni, Alberto Floris, Ignazio Cangemi, Mattia Congia, Elisabetta Chessa, Micaela Rita Naitza, Matteo Piga, Alberto Cauli |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1274539/full |
Similar Items
-
Targeted Therapies in Axial Psoriatic Arthritis
by: Alberto Floris, et al.
Published: (2021-06-01) -
The role of Anti-PAD4, Anti-CarP, and Anti-RA33 antibodies combined with RF and ACPA in predicting abatacept response in rheumatoid arthritis
by: Alberto Floris, et al.
Published: (2025-01-01) -
Gene Expression Profiling of Monozygotic Twins Affected by Psoriatic Arthritis
by: Angioni MM, et al.
Published: (2021-03-01) -
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus
by: Matteo Piga, et al.
Published: (2017-11-01) -
Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study
by: Alberto Cauli, et al.
Published: (2023-11-01)